Active Biotech completes sale of property
05 4월 2019 - 9:15PM
PRESS RELEASE Lund Sweden, April 5 2019 - Active Biotech (NASDAQ
STOCKHOLM: ACTI) Active Biotech completes sale of property
Active Biotech AB (publ) has
today completed the sale of the Company's property Forskaren 1 in
Lund.
As previously announced Active Biotech entered
into an agreement on March 13, 2019 regarding sale of the Company's
property Forskaren 1 in Lund, Sweden, with a newly formed investor
collective led by the real estate company Estea AB.
Active Biotech's largest shareholder, MGA Holding
AB, had, on the request of Estea, declared its willingness to
participate with up to 40 percent of Estea's equity financing.
Hence, the sale was conditional on approval by the shareholders of
Active Biotech. Such approval was given at the extraordinary
general meeting held on April 4, 2019, where after the sale was
completed today, April 5, 2019.
The purchase price amounts to SEK 275 million,
which corresponds to the property's book value. Together with the
rights issue of approximately SEK 47 million that was completed in
2018, the proceeds from the sale of the property are expected to
finance the Company's operations under the current business plan.
The property sale entails a capital injection of approximately SEK
70 million.
Lund April 5, 2019
Helén Tuvesson
President & CEO
For further information, please
contact:
Helén Tuvesson, CEO
Tel. +46 46 19 21 56
Hans Kolam, CFO
Tel +46 46 19 20 44
Active Biotech AB
(publ) (NASDAQ Stockholm: ACTI) is a biotechnology company with
focus on neurodegenerative/ inflammatory diseases and cancer.
Laquinimod, an orally administered small molecule with unique
immunomodulatory properties in development for neurodegenerative
diseases. ANYARA, an immunotherapy, in development for cancer
indications in partnership with NeoTX Therapeutics Ltd.
Furthermore, commercial activities are conducted for the
tasquinimod, paquinimod and SILC projects. Please visit
www.activebiotech.com for more information.
Active Biotech AB
(Corp. Reg. No. 556223-9227)
Box 724, SE-220 07 Lund, Sweden
Tel: +46 (0)46 19 20 00
This information is information
that Active Biotech AB is obliged to make public pursuant to the EU
Market Abuse Regulation. This information was submitted for
publication, through the agency of the contact person set out
above, at 14.15 p.m. CET on April 5,
2019.
Active Biotech completes sale of
property
This
announcement is distributed by West Corporation on behalf of West
Corporation clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Active Biotech via Globenewswire
Actividentity Corp (MM) (NASDAQ:ACTI)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Actividentity Corp (MM) (NASDAQ:ACTI)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024